BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

631 related articles for article (PubMed ID: 16968795)

  • 21. Atypical pituitary adenomas: incidence, clinical characteristics, and implications.
    Zada G; Woodmansee WW; Ramkissoon S; Amadio J; Nose V; Laws ER
    J Neurosurg; 2011 Feb; 114(2):336-44. PubMed ID: 20868211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK).
    Fernandez A; Karavitaki N; Wass JA
    Clin Endocrinol (Oxf); 2010 Mar; 72(3):377-82. PubMed ID: 19650784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Epidemiology of pituitary adenoma: results of the first Swiss study].
    Fontana E; Gaillard R
    Rev Med Suisse; 2009 Oct; 5(223):2172-4. PubMed ID: 19968031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pituitary macroadenomas (>3 cm) in young adulthood: Pathologic and proliferative characteristics.
    Öngürü Ö; Düz B; Şimşek H; Günal A; Gönül E
    Neurol Neurochir Pol; 2015; 49(4):212-6. PubMed ID: 26188936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pituitary adenomas--where is the treatment heading at the beginning of the 21st century?].
    Marek J
    Vnitr Lek; 2010 Jul; 56(7):690-4. PubMed ID: 20842914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple pituitary adenomas in Cushing's disease.
    Ratliff JK; Oldfield EH
    J Neurosurg; 2000 Nov; 93(5):753-61. PubMed ID: 11059654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spontaneous and medically induced cerebrospinal fluid leakage in the setting of pituitary adenomas: review of the literature.
    Lam G; Mehta V; Zada G
    Neurosurg Focus; 2012 Jun; 32(6):E2. PubMed ID: 22655691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnosis and Treatment of Pituitary Adenomas: A Review.
    Molitch ME
    JAMA; 2017 Feb; 317(5):516-524. PubMed ID: 28170483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The epidemiology and management of pituitary incidentalomas.
    Daly AF; Burlacu MC; Livadariu E; Beckers A
    Horm Res; 2007; 68 Suppl 5():195-8. PubMed ID: 18174745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of pediatric sellar tumors.
    Jane JA
    Pediatr Endocrinol Rev; 2008 Feb; 5 Suppl 2():720-6. PubMed ID: 18317443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [New developments in pituitary diseases].
    Gruber M; Willenberg HS; Bornstein SR
    Dtsch Med Wochenschr; 2012 Dec; 137(49):2540-2. PubMed ID: 23188633
    [No Abstract]   [Full Text] [Related]  

  • 32. Retrospective multicentric study of pituitary incidentalomas.
    Day PF; Guitelman M; Artese R; Fiszledjer L; Chervin A; Vitale NM; Stalldecker G; De Miguel V; Cornaló D; Alfieri A; Susana M; Gil M
    Pituitary; 2004; 7(3):145-148. PubMed ID: 16328565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Relationship between invasive pituitary adenomas and cavernus sinus and cariod artery and surgical outcomes].
    Ren ZY; Yang Y; Su CB; Wang RZ; Tao W; Ma WB; Li YN
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Feb; 27(1):13-7. PubMed ID: 15782485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinicopathological significance of baseline T2-weighted signal intensity in functional pituitary adenomas.
    Dogansen SC; Yalin GY; Tanrikulu S; Tekin S; Nizam N; Bilgic B; Sencer S; Yarman S
    Pituitary; 2018 Aug; 21(4):347-354. PubMed ID: 29460202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased prevalence of psychopathology and maladaptive personality traits after long-term cure of Cushing's disease.
    Tiemensma J; Biermasz NR; Middelkoop HA; van der Mast RC; Romijn JA; Pereira AM
    J Clin Endocrinol Metab; 2010 Oct; 95(10):E129-41. PubMed ID: 20660031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pediatric pituitary adenomas in Northeast Mexico. A follow-up study.
    Torres-García L; Cerda-Flores RM; Márquez M
    Endocrine; 2018 Nov; 62(2):361-370. PubMed ID: 30171518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The development and validation of the Leiden Bother and Needs Questionnaire for patients with pituitary disease: the LBNQ-Pituitary.
    Andela CD; Scharloo M; Ramondt S; Tiemensma J; Husson O; Llahana S; Pereira AM; Kaptein AA; Kamminga NG; Biermasz NR
    Pituitary; 2016 Jun; 19(3):293-302. PubMed ID: 26809957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aromatase P450 expression in human pituitary adenomas.
    Gonzales PH; Mezzomo LC; Ferreira NP; Roehe AV; Kohek MB; Oliveira Mda C
    Neuropathology; 2015 Feb; 35(1):16-23. PubMed ID: 25410472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Age-related and gender-related occurrence of pituitary adenomas.
    Mindermann T; Wilson CB
    Clin Endocrinol (Oxf); 1994 Sep; 41(3):359-64. PubMed ID: 7893282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pituitary Adenomas: What Are the Key Features? What Are the Current Treatments? Where Is the Future Taking Us?
    Solari D; Pivonello R; Caggiano C; Guadagno E; Chiaramonte C; Miccoli G; Cavallo LM; Del Basso De Caro M; Colao A; Cappabianca P
    World Neurosurg; 2019 Jul; 127():695-709. PubMed ID: 31266132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.